A Study to Test Different Doses of BI 1701963 Alone and Combined With Trametinib in Patients With Different Types of Advanced Cancer (Solid Tumours With KRAS Mutation)
A Study to Test Different Doses of BI 1701963 Alone and Combined With Trametinib in Patients With Different Types of Advanced Cancer (Solid Tumours With KRAS Mutation)
Active, not recruiting · NCT04111458 · Registry updated 2026-09-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Test Different Doses of BI 1701963 Alone and Combined With Trametinib in Patients With Different Types of Advanced Cancer (Solid Tumours With KRAS Mutation) | Solid Tumors, KRAS Mutation; SOS1 | Active, not recruiting | Phase 1 | 2026-09-29 | NCT04111458 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Boehringer Ingelheim | 158 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dana-Farber Cancer Institute | Boston | United States | 626 |
| Erasmus Medisch Centrum-ROTTERDAM-50697 | Rotterdam | Netherlands | 4 |
| Levine Cancer Institute | Charlotte | United States | 110 |
| Sarah Cannon Research Institute-Nashville-48456 | Nashville | United States | 3 |
| The University of Texas MD Anderson Cancer Center | Houston | United States | 207 |
| Universitair Medisch Centrum Utrecht | Utrecht | Netherlands | 49 |
| Universitätsklinikum Frankfurt | Frankfurt am Main | Germany | 5 |
| Universitätsklinikum Köln (AöR) | Cologne | Germany | 13 |